Bill Town, Chair of the Awards Committee of the American Chemical Society Division of Chemical Information (ACS CINF) announced that Prof.Dr. Hugo Kubinyi, Advisor to the Chair and Past Chair of the QSAR and Modeling Society, was to receive the 2006 Herman Skolnik Award at the Fall ACS meeting in San Francisco. According the official ACS CINF web site, Hugo Kubinyi was selected "for his extensive contributions to cheminformatics, QSAR, and combinatorial chemistry through over 100 publications, six books, and over 35 years of active service in drug design.

Hugo Kubinyi was born in Vienna, Austria in 1940 and completed his studies of Chemistry in Vienna, Austria and at the Max Planck Institute of Biochemistry, Munich, Germany with a PhD Thesis on the Isolation, Structure, Elucidation and Partial Synthesis of Phorbol Esters. From 1965-1966 he was at the German Cancer Research Center (DKFZ) in Heidelberg, and in 1966 he moved to Knoll AG (now Abbott GmbH & Co. KG), Ludwigshafen, Germany where he was Research Scientist, Natural Products, Project Manager Chemical Research, and, in 1972-1984, Department Head of Natural Products Research.

In 1985 he moved to BASF AG, Ludwigshafen, where he was Head of Drug Design (Molecular Modelling and Protein Crystallography) from 1987-1998, and Head of Combinatorial Chemistry and Molecular Modelling (including Protein Crystallography and Drug Design) from 1998-2001. From 1986 he was also Professor of Pharmaceutical Chemistry at the University of Heidelberg.

In his career, he has received many awards and has published five books on QSAR, 3D QSAR, and Drug Design. He is also Editor of the Wiley-VCH book series Methods and Principles in Medicinal Chemistry together with Raimund Mannhold, University of Düsseldorf, Germany, and Gerd Folkers, ETH Zurich, Switzerland. He was Vice-Chair (1991) and Chair (1993) of the Gordon Research Conferences on Quantitative Structure-Activity Relationships, 1995-2000 Chair of  the QSAR and Modelling Society (Deputy Chair 2001-2005) and member of the Editorial Boards of the journals Current Drug Discovery, Current Opinion in Drug Discovery & Development, Journal of Chemical Information and Computer Sciences, Medicinal Chemistry Research, and Quantitative Structure-Activity Relationships, Highlight Advisor of Nature Reviews in Drug Discovery and a Member of the Scientific Advisory Boards of several software and start-up companies.

The QSAR and Modelling Society congratulates Hugo Kubinyi on this well-deserved recognition.